News
Researchers have discovered which dog breeds are more likely to get cancer, and the results disprove the notion that large dogs have a higher risk of the disease.
People with locally advanced head and neck squamous cell carcinoma (HNSCC) now have a new treatment option that could extend their lives with fewer side effects. The U.S. Food and Drug Administration ...
Neo-adjuvant nivolumab or nivolumab with ipilimumab in advanced cutaneous squamous cell carcinoma prior to surgery. ClinicalTrials.gov. Updated October 26, 2022.
The receptor for the complement component C5a may be a useful therapeutic target for cases of cutaneous squamous cell carcinoma (cSCC), according to a new report. 1 The study, published in the ...
Traws Pharma published key clinical efficacy data for rigosertib in patients with RDEB-associated squamous cell carcinoma. What is rigosertib being evaluated for?
Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...
Survival for head and neck squamous cell carcinoma treated with versus without neoadjuvant systemic therapy: A national propensity score–matched analysis.. If you have the appropriate software ...
A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery.
Mohs surgery significantly improved recurrence, metastasis, and mortality rates in patients with primary high-stage cutaneous cell carcinoma in a retrospective cohort study of 216 patients treated ...
Leonard-Neverov, of Phoenix, Arizona, told Newsweek: "Remington's official diagnosis was papillary squamous cell carcinoma, a type of cancer that affects the mouth.
“Oral squamous cell carcinoma is the second-most common malignant oral tumor in dogs, and this papillary subtype has previously been reported in young dogs.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results